Skip to main content

What's on the Horizon for Chronic Myeloid Leukemia?

September 27, 2017

[Click here to enlarge.] 

Topics Covered

We invite you to learn more about:

  • Diagnosing chronic myeloid leukemia (CML)
  • Emerging therapies for CML
  • Side-effects management
  • Communicating with your healthcare team



Michael J. Mauro, MD
Leader, Myeloproliferative Neoplasms Program
Clinical Director, Leukemia Service
Attending Physician and Member
Memorial Sloan Kettering Cancer Center
Professor of Medicine
Weill Cornell Medical College
New York, NY

Audio Replay

Program Materials

Program Support

Support for this program is provided by Bristol-Myers Squibb, Novartis and Takeda Oncology.